May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

Mitochondrial mutation MT haplogroup T strongly predicts poor response to immune checkpoint inhibitors in metastatic melanoma ...

A perfect storm of scientific, economic, and cultural barriers are holding back immunotherapy's true potential, writes Samir ...

An innovative treatment called lifileucel, which uses a patient's own immune system to combat advanced melanoma, has shown ...

Mitochondrial DNA emerges as a key factor in melanoma checkpoint inhibitor resistance, revealing new potential biomarker for patients.

Existing drug class may help patients with skin cancer to resist standard treatments: Study: New York Friday, June 13, 2025, 16:00 Hrs [IST] An increased activity in a specific bi ...

A Philadelphia cancer patient will be honored at the Phillies' game on Tuesday night. Josh Breen, who was diagnosed with ...

Melanoma is the most prevalent cancer during pregnancy, representing 31% of all gestational cancers, and that number is ...

Josh Breen, who was diagnosed with stage 3 melanoma last year, will throw out the first pitch at Tuesday's Phillies' game as ...

Emerging research is uncovering how a fiber-rich, whole-foods-based diet may help support better outcomes for patients ...

In Colorado, about one-in-two men and two-in-five women will be diagnosed with some form of cancer in their lifetimes. It's a ...